Clinical Trial Update: Apathy in Dementia Methylphenidate Trial (ADMET) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating methylphenidate for apathy in Alzheimer's disease completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Apathy, Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-05-10